• In The News

Walter Reed Study on CTR Procedures Selected for Award at 2024 SOMOS Meeting

Dec 5th, 2024

Walter Reed Study Awarded at 2024 SOMOS Meeting

An innovative study conducted at Walter Reed National Military Medical Center, led by Principal Investigator LTC Matthew Miller, MD, and colleagues, explored the feasibility of two techniques for carpal tunnel release: ultrasound-guided (CTR-US) and mini-open carpal tunnel release (mOCTR).

This single-site, randomized controlled trial involved 41 participants, including 17 active duty military personnel, who were assigned to receive either CTR-US performed by Physical Medicine and Rehabilitation (PM&R) physicians using the commercially available device, UltraGuideCTR, or mOCTR performed by Orthopedic Hand Surgeons. CTR-US procedures resulted in smaller incisions (5.4 mm in the wrist vs. 28.0 mm in the palm), less incisional pain, and reduced opioid use in the early postoperative period. Importantly, both groups demonstrated comparable outcomes at the 1- and 3-month follow-ups.

All participants have completed their 3-month follow-up, with ongoing monitoring planned for a total of two years. The findings will be presented at the Annual Meeting of the Society of Military Orthopaedic Surgeons (SOMOS) from December 9-13, 2024, in Nashville, TN, where the paper has been selected for the Jamie Dianne Bulken-Hoover Memorial Best Hand Paper Award.

This research study was supported by the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program, based in the Department of PM&R at the Uniformed Services University.

DISCLAIMER: The views expressed herein are those of the author(s) and do not necessarily reflect the official policy of the Department of Defense or the U.S. Government. Mention of trade names, commercial products or organizations does not imply endorsement by the U.S. Government.

The opinions and assertions expressed herein are those of the author(s) and do not necessarily reflect the official policy or position of the Uniformed Services University.

About Sonex Health

Sonex Health, Inc. is a leader in innovative ultrasound-guided therapies to treat common orthopedic conditions affecting the extremities, including entrapment neuropathies and tendinopathies. The company’s proprietary devices allow surgeons to use real-time ultrasound guidance to visualize critical anatomy throughout procedures, thereby reducing both invasiveness and the cost of care, and enabling patients to return to their normal activities sooner. The company’s first commercial device, UltraGuideCTR™, was designed to treat carpal tunnel syndrome and received FDA clearance in 2019. The company’s second commercial device, UltraGuideTFR™ was designed to treat trigger finger, also known as stenosing tenosynovitis, and was released in 2022.

For information about Sonex Health, UltraGuideCTR, and UltraGuideTFR visit www.sonexhealth.com.

About the Institute of Advanced Ultrasound Guided Procedures

Founded in 2018 to support the Sonex Health mission and clinical excellence, the Institute of Advanced Ultrasound Guided Procedures is focused on innovation supported by robust clinical research and world-class professional education and training that transforms the treatment experience for patients, providers, and payers. For more information about the Institute visit www.sonexhealth.com/educational-institute.